Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRO
1876
DELISTED
PROS Holdings
PRO
| $12.4M | ﹤0.01% |
342,053
+5,830
| +2% | +$206K |
|
1877
Designer Brands
DBI
$330M
| $12.4M | ﹤0.01% |
1,135,058
+68,886
| +6% | +$660K |
|
1878
National Bank Holdings
NBHC
$1.93B
| $12.4M | ﹤0.01% |
343,142
+31,540
| +10% | +$1.09M |
|
1879
Rocket Companies
RKT
$38.8B
| $12.3M | ﹤0.01% |
848,725
+131,751
| +18% | +$1.64M |
|
1880
Standard Motor Products
SMP
$863M
| $12.3M | ﹤0.01% |
367,206
+5,951
| +2% | +$218K |
|
1881
Schrodinger
SDGR
$1.15B
| $12.3M | ﹤0.01% |
456,057
+12,573
| +3% | +$352K |
|
1882
Capitol Federal Financial
CFFN
$1.13B
| $12.3M | ﹤0.01% |
2,063,533
+119,673
| +6% | +$712K |
|
|
TBI
1883
Trueblue
TBI
$233M
| $12.3M | ﹤0.01% |
982,037
+84,685
| +9% | +$1.1M |
|
1884
Certara
CERT
$1.28B
| $12.3M | ﹤0.01% |
687,220
+51,229
| +8% | +$884K |
|
1885
Bank of N.T. Butterfield & Son
NTB
$2.46B
| $12.3M | ﹤0.01% |
383,388
+22,488
| +6% | +$684K |
|
1886
Schwab High Yield Bond ETF
SCYB
$2.75B
| $12.2M | ﹤0.01% |
469,396
+130,798
| +39% | +$3.39M |
|
|
EHAB
1887
DELISTED
Enhabit
EHAB
| $12.2M | ﹤0.01% |
1,050,351
+83,836
| +9% | +$840K |
|
1888
Xencor
XNCR
$1.42B
| $12.2M | ﹤0.01% |
552,922
+32,224
| +6% | +$696K |
|
1889
Plug Power
PLUG
$2.87B
| $12.2M | ﹤0.01% |
3,553,132
+178,350
| +5% | +$663K |
|
|
AVNS
1890
DELISTED
Avanos Medical
AVNS
| $12.2M | ﹤0.01% |
613,113
+49,959
| +9% | +$966K |
|
1891
Myers Industries
MYE
$1.37B
| $12.2M | ﹤0.01% |
526,088
+38,363
| +8% | +$759K |
|
|
SP
1892
DELISTED
SP Plus Corporation
SP
| $12.2M | ﹤0.01% |
232,980
+1,502
| +0.6% | +$77.5K |
|
1893
FB Financial Corp
FBK
$3.05B
| $12.1M | ﹤0.01% |
322,340
+31,003
| +11% | +$1.14M |
|
1894
BJ's Restaurants
BJRI
$1.42B
| $12.1M | ﹤0.01% |
335,365
+8,106
| +2% | +$282K |
|
1895
MGP Ingredients
MGPI
$372M
| $12.1M | ﹤0.01% |
140,854
+15,856
| +13% | +$1.37M |
|
1896
Ironwood Pharmaceuticals
IRWD
$733M
| $12.1M | ﹤0.01% |
1,392,403
+103,750
| +8% | +$1.26M |
|
1897
Upwork
UPWK
$1.18B
| $12.1M | ﹤0.01% |
988,360
+11,287
| +1% | +$154K |
|
1898
Pacira BioSciences
PCRX
$1.04B
| $12.1M | ﹤0.01% |
414,151
+42,485
| +11% | +$1.31M |
|
1899
Marcus & Millichap
MMI
$1.16B
| $12.1M | ﹤0.01% |
353,938
+6,903
| +2% | +$253K |
|
1900
Recursion Pharmaceuticals
RXRX
$1.68B
| $12.1M | ﹤0.01% |
1,213,012
+22,130
| +2% | +$246K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.